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In the course of a study conducted by investigators in the Division of Medi- 
cine  and  Public  Health  of  The  Rockefeller  Foundation  on  the  serological 
relationships and the epidemiology of certain arthropod-borne virus infections, 
it was  thought  that application of the hemagglutination  (HA)  test might be 
useful in elucidating some of the problems. 
Specific hemagglutination (HA) with certain neurotropic viruses was first reported 
by Hallauer (1), Lahelle and Horsfall (2), and Olitsky and Yager (3). In the arthro- 
pod-borne group, Hallauer (4) stated that he had obtained an agglutinating antigen 
from viscerotropic but  not  from neurotropic strains  of yellow  fever virus.  It was, 
however,  Sabin  and  his  associates  (5-10)  who  showed  the  existence  of HA with 
arthropod-borne viruses generally,  among them dengue Types 1 and 2, Japanese B, 
St. Louis, Russian Far Eastern, Uganda S, West Nile, and Western equine encepha- 
litis  (WEE).  Chanock and  Sabin  (8-10)  described  in  detail the optimal conditions 
for carrying out the tests, emphasizing the proper choice of erythrocytes as to both 
species and age of the donor animals, and a  satisfactory method for removing non- 
specific inhibitory substances from sera.  Furthermore, they showed  the existence  of 
cross-reactions  among different viruses  and  their  antisera.  MacDonald  (11),  using 
newborn-mouse  brain as the source of material, later prepared a hemagglutinin from 
Murray Valley encephalitis  virus. 
In  a  previous  communication  by  the  present  authors  (12),  a  new  method  was 
described  for the preparation of hemagglutinins for chick  erythrocytes with the fol- 
lowing  viruses: dengue Types 1 and 2,  Ilh6us,  Japanese B, Ntaya, West Nile, and 
yellow fever. 
It is the purpose of the present paper:  (a)  to describe an extension of the 
results of the earlier work to other viruses in this group; (b) to show that with 
the  methods  developed,  two  types  of  hemagglutinins  have  been  observed; 
and  (c)  to note that on the basis of the behavior of their agglutinins,  as well 
as from the results of HA inhibition tests, a number of arthropod-borne viruses 
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can be classified into two sharply different groups, designated A  and B. Group A 
consists of Eastern  equine encephalitis  (EEE),  Semliki Forest,  Sindbis, Vene- 
zuelan equine encephalitis (VEE), and WEE  viruses; Group B  includes dengue 
Types  1  and 2, Ilh6us, Japanese B, louping ill, Ntaya,  St. Louis,  Russian Far 
Eastern,  Uganda  S,  West  Nile,  and yellow  fever viruses. 
Materials and Methods 
Viruses.--The viruses tested for their capacity to show HA are listed in Table I. Some 
of the viruses are not of the arthropod-borne group; however, they were included in this 
TABLE  I 
Viruses Tested  for Capadty to Yield Hemagglutinins 
Virus and reference 
to source 
~knopheles A  (13) 
',aliforuia  (14) 
Dengue  Type 1  (15) 
Dengue Type 2  (16) 
GEE  (17) 
[lh~us  (lS) 
Japanese B  (19) 
~taya  (20) 
?ollomyelitis  (21 ) 
l~pe2 
Rabies  (22) 
Russian Far  (23) 
Eastern 
3t. Louis  (8) 
~emlikl Forest  (24) 
Strain 
BFS--283 
Hawaiian 
New Guinea B 
Rockefeller 
Institute 
Nakayama 
MEFI 
Pasteur 
Parton 
No. of passages 
tlt nllce 
z 
166  2 
?  5 
75  2-6 
0  46 
Over 200  2-6 
25  2--6 
100-200  2-10 
10"  4-6 
20  140 
199"  2 
10-20"  1 
21  2-4 
7  2-4 
Virus and reference! 
to source 
Sindbis 
Uganda S 
VEE 
West Nile 
West Nile 
WEE 
WEE 
Wyeomyia 
Yellow fever  (32) 
Yellow fever  (33) 
Yellow fever (34) 
Yellow fever  (34) 
Yellow fever  (35) 
Strain 
! 
F 339 
(26) 1 
(27) I 
(28) , B 956 
(29) [ Egypt 101 
! 
(30)  McMillau 
(31) ! North Dakota 
(13)[ 
. Asibi 
French neuro- 
tropic 
JSS 
Ogbomosho 
17 D 
NO. Of 
pas~ges 
In mice 
X 
0  10 
21  2 
?  2-4 
3o  1 
o*  5-8 
6-10  6-8 
1-2"  1-2 
204  1-2 
o*  2-4 
260  1-5 
5-10  1-5 
5-10  1-5 
0*  1-5 
"For passages in other animal species, see text. 
study to investigate the possibility of the methods applying to other agents, and also to 
serve as a  control. 
Table I gives ascertainable data concerning the number of passages in mice for each virus. 
From the time of their isolation or shortly thereafter, the viruses for the most part had been 
maintained in  adult  mice in  this or  other laboratories.  Exceptions were  dengue Type  2, 
Sindbis, and the Egypt 101 strain of West Nile, all of which had no passages in adult mice. 
Ntaya  after propagation in adult  mice was  passed through chick embryos 7  times,  then 
through newborn mice. Rabies virus had been maintained in rabbits for about 1,500 passages 
when received in this laboratory, at which time adult mouse passages were initiated. The 
passages reported for Russian Far Eastern virus are those known to have taken place in this 
country; the previous history of this virus is not known. The Egypt 101 strain of West Nile 
virus was propagated in chick embryos for 5 passages. The North Dakota strain of WEE 
had been through 11 passages in guinea pigs prior to injection into mice. Of the yellow fever JORDI CASALS AND LENORA V. BROWN  431 
strains, Asibi had been maintained in monkeys for an undetermined number of passages and 
17 D  had been propagated  in chick embryo tissue culture.  The passages in newborn mice 
as they appear in Table I  were in addition to the previous passages in adult mice or other 
species, or in tissue cultures. 
All the  viruses could be readily passaged  in newborn  mice with the exceptions of the 
dengue viruses (15,  16) and poliomyelitis Type 2 (21).  Antigens for the HA tests were pre- 
pared with central nervous system (CNS) tissue of the newborn-mouse passages. 
M~2e.--The newborn  mice used in preparation  of the HA antigens were raised in this 
laboratory and belonged to a strain of Swiss mice free of Theiler's virus. As a rule, mice were 
inoculated when 3 or 4 days old. However, with viruses such as EEE and WEE which have 
a short incubation period, the animals were injected when 7 or 8 days old, and with viruses 
having a  longer period, when 1 or 2 days old. The procedure for harvesting CNS tissue has 
been described (36).  It is to be noted here that, in general, the HA antigens used in these 
tests were not prepared from freshly harvested tissue, but rather from tissue that had been 
held at  --20°C. for as much as several weeks. 
Preparation and Preservation of Antigens for HA  Tests.--The method used in preparing 
the extracts to be employed in the HA tests--referred to hereafter as antigens--is the one 
used for the preparation  of complement-fixlng antigens (36);  in fact, the same preparations 
were used interchangeahly. Essentially, the procedure comprised extracting the infected CNS 
tissue twice with 20 volumes of acetone, once with a  mixture of equal parts of acetone and 
ether, and twice again with 20 volumes of ether. After evaporation of the ether, the extracted 
tissue was resuspended in physiological saline in a proportion of 1 gin. of the original tissue 
and 2 ml. of saline; the supernatant fluid, after centrifugation at about 9,000 g for one hour, 
constituted  the  antigen.  The antigen  thus  represented  a  33  per cent suspension  of  CNS 
tissue in saline; in this paper, the titers of hemagglutinins are expressed in terms of dilution 
of this 33  per cent suspension--designated  undiluted antigen--not in terms of dilution of 
CNS tissue. It is to be noted also that no buffering system was added to the antigens while 
they were being prepared or upon completion; their pH was between 7.2 and 7.5. 
Antigens are now preserved routinely at -20°C. in lyophilized form. Under these condi- 
tions  the titer has remained unchanged  for months; lyophilization itself may occasionally 
result in a  moderate loss of titer. This mode of preservation has not as yet been tried with 
Uganda S and yellow fever antigens. Antigens have also been preserved at  --20°C. in the 
frozen state with no appreciable loss of titer when so kept for several months; a given sample 
was thawed not more than 3 or 4 times, since repeated freezing and thawing could result in a 
loss of titer. 
Sera.--The sera used  in  the present  study were obtained  from mice, guinea pigs,  and 
monkeys (Maca~us rhesus). The number of injections of formolized or active virus given to 
an animal was, for mice, 5 to 7; this constituted a hyperimmune serum. Guinea pigs received 
fewer injections, either 1 or from 3 to 4; their sera were designated immune sera. Monkeys, 
on the other hand, were given only 1 injection of active virus, which resulted in either febrile 
response or circulating virus or both, followed by recovery; these scra were therefore marked 
as convalescent. Thus it was considered that with the different sera--hyperimmune, immune, 
and  convalescent--it might be possible to detect any serological crossings as well as viral 
spedfidty. 
Mouse sera were prepared against 22 viruses or strains, following a course of vaccination 
and bleeding to which close attention was paid in order to have comparable results. Groups 
of 60 mice, 5 to 7 weeks old, were immunized as follows: all injections were 0.2 ml. in volume, 
given intraperitoneally, and consisted of a  l0 per cent suspension of infected newborn-mouse 
CNS tissue. The first 2 injections given on the 1st and 3rd days respectively were of virus to 
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kept at 4°C. for 1 week at least. The remaining injections, given on the 10th, 15th, and 20th 
days, were of active virus; the mice were bled from the heart under ether anesthesia on  the 
28th or 30th day. Often on the 45th day a  6th injection of active virus was given, and the 
mice were rebled 1 week later. The serum pools were kept at -20°C. These sera were tested 
for and found to have complement-fixing antibodies in aU cases, including those that failed 
to react in the HA inhibition system, as will be discussed later. 
Some of the guinea pig immune sera were obtained through the courtesy of Dr. J. A. Kerr 
and were prepared as described by him (37), through repeated injections of virus. For Ilh6us, 
Japanese B, St. Louis, and Sindbis viruses, immune sera were obtained by bleeding animals 
that had received a  single intracerebral injection of newborn-mouse CNS  virus in dilution 
10  -I (38). These animals failed to show any signs of illness, including fever, yet developed 
antibodies. 
Monkey sera were derived from animals bled at intervals during the course of convales- 
cence and recovery after an experimental infection; these scra were kept lyophilized at 4°C. 
or at --76°C. For each animal a series of sera was available, comprising a sample taken before 
infection and several taken at different times after infection, extending in some cases over a 
period of 1 year. 
D//uen/s.--Glass-distilled water was used in all phases of the test, except for preparation 
of the antigens. As diluent for the chick erythrocytes, a 0.9 per cent solution of sodium chlo- 
ride was used. The diluent for the antigens and sera was a  0.9 per cent solution of sodium 
chloride containing a phosphate buffer system 0.1 ~  designated "standard diluent." Actually 
0.1 ~t solutions were prepared of Na~PO~ and KHsPO4 in 0.9 per cent sodium chloride; by 
m~iug adequate amounts of the two, the pH range from 6 to 8 was covered, determinations 
being made in a  Beckman pH meter. The ionic strength of the standard diluent was there- 
fore 0.3 ~1. As will be seen later, the final mixture in the tubes of a  given test had an ionic 
strength of approximately 0.22 N; this concentration of electrolyte did not result in any ap- 
parent damage  to  the erythrocytes, as  judged by  adequate  controls, yet it enhanced the 
sharpness and stability of the precipitating patterns or shields and, especially with the anti- 
gens derived from Group A, produced more clearly defined titration end-points and often 
higher titers. When phosphate buffer 0.02 It in physiological saline was used (9), the results 
of the tests were in close agreement with those secured using the more concentrated buffer 
although, in general, they were somewhat less well defined. When a pH lower than 6.0 was 
required, usually between 5.5 and 6.0, phtlmlate buffer (9) was used; the pH ranges below 
6.0 and above 8.0 have not, however, been investigated extensively. 
Preparation of Sera for HA Inhibition  Tests.--A method was developed for removing non- 
specific inhibitors from  sera  to be used  in  the  HA  inhibition tests.  The  procedure,  now 
routine, consists of filtering the sera through Seitz pads in the following manner: of a  given 
serum, an amount ranging from 0.4 ml. to 0.8 ml. was diluted to 1:10 in standard diluent at 
pH 7.0.  Two Seitz E-K pads were put in a  filter casing and 10 ml. of the same diluent was 
passed through at 5 pounds positive pressure; when the fluid was exhausted, the diluted serum 
was introduced in the filter and allowed to go through slowly by using a positive pressure of 
1 to 2 pounds. The filtered sera no longer retained non-specific inhibitors, and were stored 
at --20°C. until used. The sera thus treated had a pH about 7.0 and could therefore be used 
directly with those antigens which required this pH; i.e., Group B. But with antigens requir- 
ing a pH 6.4, Group A, an adjustment was made by adding to the serum thus filtered a suffi- 
cient amount of a  10 per cent solution of HC1; this amount was found to be 0.03 ml./ml. 
of the diluted serum. In this laboratory filtration could be carried out simultaneously on 
12 sera by means of a  manifold pressure outlet. It was found that in the course of a regular 
work-day a  person, while still otherwise engaged, could prepare 48 sera with a  yield of 6 to 
7 ml., which was a  sufficient quantity for 12 to 14 titrations at an initial dilution of 1:10. JORDI  CASALS AND  LENOP~  V.  BROWN  433 
Erythrocytes.--The method described by Chanock and Sabin (8)  was rigidly adhered to. 
One-day-old chicks were bled from the heart under ether anesthesia using Alsever's solution 
as a preservative as well as anticoagulant; the proportion of blood to Alsever's solution was 
1 to 4. The blood was not used until after it had remained in the refrigerator at 4°C. for 48 
hours; then it was used for the next 5 or 6 days. When needed, a  sufficient amount of blood 
was centrifuged and the sedimented cells were washed 3  times and resuspended in physio- 
logical saline at a  concentration of 0.25 per cent; of this suspension, cooled at I°C., 0.5 ml. 
per tube was used in the tests. 
The use of other erythrocytes, whether from older chicks or from other animal species, 
man or sheep, was not generally satisfactory and therefore abandoned. 
Performance and Reading of Tests.--All tests were conducted in tubes measuring 75 by 
12 ram., specially tooled so as to have a  uniform inside bottom surface. 
Titration of antigen: A new lot of antigen was titrated in the following manner: in each of a 
series of 12 to 16 tubes was measured 0.5 ml. of standard diluent at pH 6.4 or 7.0, depending 
on the virus; the tubes were placed in an ice-water bath at I°C. and when chilled, the antigen 
was diluted in increasing twofold dilutions beginning at 1:4 or 1:8. Then 0.5 ml. of the red 
cell suspension was added to each tube; the tubes were shaken and put in a  cold room at 
4°C. for the viruses of Group B or in a water bath at 37°C. for those of Group A; for yellow 
fever antigens the incubation was done at room temperature (22°C.). 
When investigating new  viruses or strains for their ability to induce HA,  titrations as 
just described were carried out at pH 5.6, 6.0,  6.4,  6.8,  7.0, and 7.6; for each pH a  titration 
was set up in triplicate, one being incubated at 370C., another at 22°C., and the third at 4°C. 
In all cases adequate control tubes were included, with erythrocyte suspension alone in the 
same final volume. 
With the exceptions noted later, the pattern of agglutination was as illustrated by Chanock 
and  Sabin  (8);  namely,  positive agglutination consisted of a  smooth  deposit  or  shield of 
erythrocytes covering the entire bottom surface of the tube; a negative result was seen  as a 
button of sedimented cells covering only the lowermost portion of the bottom. No agglutina- 
tion was recorded as 0 and complete agglutination as ++;  intermediate degrees were repre- 
sented as +  when there was a  shield surrounded by a  light ring of cells,  and -4- for a  lesser 
degree of reaction. The reading of a  test could be done in 2 hours when the incubation was 
at 4°C.,  sooner when incubated at 220C.  or 37°C.  At any time thereafter during the  next 
24 hours or even longer, the pattern of agglutination remained practically unchanged.  The 
titer of an antigen was given by the highest dilution showing a  +  agglutination or  better; 
this amount of antigen represented 1 unit. In tubes containing the higher concentrations of 
antigen, 1:4 to 1:128, there was often a  tendency toward slippage and folding over of  the 
sheet of erythrocytes,  as already observed  (8);  this did not interfere with the reading  of 
the test. 
With some preparations, particularly those derived from dengue viruses, the pattern of 
agglutination was at times of a  coarse nature as though large clumps of red cells had fallen 
to the bottom of the tube. With viruses of Group A, the reaction was of a somewhat different 
type in that it consisted of both agglutination and hemolysis; ordinarily with the higher con- 
centrations of high-titered antigens, hemolysis was complete, then became less marked as 
the amount of antigen decreased,  and in the highest dilutions approaching the end-point, 
none was  apparent.  The  reading of the  test in the  last  case was  done by observing and 
recording completeness of reaction, whether agglutination or hemolysis. 
HA inhibition  tests ugth serum: Tests to investigate serum inhibition of HA were carried 
out in the following manner: an ampule of lyophilized antigen was rehydrated, care being 
taken in this and all subsequent steps to hold the antigen, whether diluted or undiluted, 
at  I°C.  Using standard diluent at pH 6.4 or 7.0,  depending on the virus, a  portion of the 434  AGGLUTINATION BY  ARTHROPOD-BORNE VIRUSES 
antigen was brought to a dilution which from previous experience could be expected to yield 
between 8 and 16 units. This diluted antigen was then titrated twice to make up the prelimi- 
nary titrations--once immediately and then 10 minutes later. While awaiting the result of 
the titrations, the sere to be tested were diluted in seriai twofold dihtions in standard diluent 
at the same pH at which the antigen was being titrated. The first dilution of serum was 
usually 1:10, rarely 1:5; the number of dilutions was, as a rule, not fewer than 6 tubes per 
serum. The amount used in each dilution was 0.25 ml. Dilution of the sets was done at room 
temperature and when completed, the racks were placed in a cold room until the remaining 
reagents were added. 
As soon as the titer of the antigen had been determined, the diluted sera were placed in 
an ice-water bath at 1°C.; red cell suspension was added (10) in amounts of 0.5 ml. per tube. 
Then from the pre|imlnary titrations was deduced the dilution of antigen which in 0.25 ml. 
would contain 8 units; a sufficient amount was prepared from the same ampule of antigen 
used for the preliminary titrations. Of the diluted antigen 0.25 ml. was added to each tube, 
and the tubes were shaken and incubated at the required temperature. A sample of the diluted 
antigen that had been added to the tubes was then titrated; almost invariably its titer was 
found to be identieal with that shown in the preliminary titrations. When the number of 
tubes in a test was greater than 150, the test was divided into 2 or more sections, each con- 
raining no more than that number of tubes, and each treated as a different test in that differ- 
ent batches of diluted antigen were prepared from the same original sample and each titrated 
at the end of its run. The entire test was then placed at either 4°C. or 37°C., or at 22°C. in 
the case of yellow fever antigens. 
Serum inhibition of HA was also carried out in a similar manner, with a constant dilution 
of serum and increasing dilutions of antigen. 
EXPE]~  ~r~NTAL 
Stability  and  General Properties  of  Hemagglutinating  Antigens.--Extracts 
capable of agglutinating 1-day-old chick erythrocytes have been prepared from 
the following viruses: dengue Type 1, dengue Type 2, EEE, Ilh~us, Japanese B, 
Ntaya,  St.  Louis,  Sindbis, Uganda  S, "fEE,  West Nile  (Egypt  101),  WEE, 
and yellow fever  (Asibi, French neurotropic, and  JSS  strains).  Antigens de- 
riving from dengue Type 2 virus have usually been poor, i.e. of low titer and 
giving a  coarse pattern of HA; in serum inhibition tests the antigen was un- 
satisfactory  and  not  used  extensively.  Antigens  from  dengue  Type  1  were 
similarly unsatisfactory in  3  out  of  8  different preparations.  The  remaining 
antigens have  been  easily prepared on  repeated occasions, yielding clear-cut 
titxations and serum inhibition tests. 
Antigens held frozen at  --20°C., or lyophilized and kept at either --20  ° or 
4°C.,  showed  no  appreciable loss of titer for periods of time extending to  9 
months,  the longest period tested. If held at 4°C.  in undiluted fluid form, no 
loss of titer was noted in 48 hours with samples of West Nile (Egypt 101) and 
dengue Type 1. With none of the undiluted antigens was there any detectable 
loss of titer when kept for  2  hours  at  I°C. 
The keeping properties described above refer to the antigens in undiluted 
form; since high dilutions were often necessary for the tests it became desirable 
to examine their stability in diluted form and at different pH values. e~ 
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In Table II are reported experiments in which each antigen was diluted to 1 : 16 in standard 
diluent at the indicated pH; this dilution, held at 1°C.,  was titrated after different periods 
of time. The diluent for the titration was in each case at the same pH as that of the initial 
1:16 dilution. It can be seen that, for the antigens tested, the range of reaction extended 
from pH 6.4 to 7.2 and even 7.6; and that at pH 7.0, which may not necessarily be the opti- 
mum in terms of titer, all antigens with the exception of dengue Type 2 were active in high 
titers and stable for periods ranging from 1 to 4 hours. 
TABLE  III 
Stability at pH 7.0 of Heraagglutinal~ng Antigens in Dilutions 
Dilution and time tested in hra 
Antigen  1:16  1:64  1:256 
0  1  2  4  0  1  2  4  0  1  2  4 
Dengue Type 1 
Japanese B 
Ntaya 
St.  Louis 
West Nile 
(Egypt 101) 
1,024  1,024  1,024  1,024 
16,384  16,384  16,384  8,192 
1,024  512  512  32 
16,384  16,384  8,192  8,192 
2,048  2,048  1,024  512 
1,024  1,024  1,024  1,024 
8,192  8,192 8,192  4,096 
512  512  512  <64 
16,384  8,192 2,048 2,048 
2,048  1,024  512  128 
1,024  1,024  1,024 1,024 
16,384  8,192  8,192 4,096 
1,024  512  256  256 
8,192  8,192 1,024  1,024 
2,048  1,024  512  <256 
TABLE  IV 
Stability  of Hemagglulinaling Antigens  Held at High Dilulions for Short Inter~als 
Reciprocal of l  Min. 
Antigen  pH  antigen  di-  [ 
lution 
EEE 
tEE 
WEE 
Dengue Type 1 
Dengue Type 2 
[lh6us 
Japanese B 
Uganda S 
6.4 
6.4 
6.4 
7.0 
7.0 
7.0 
7.0 
7.0 
500 
400 
200 
128 
30 
1,600 
2,000 
250 
0  s  10 
4,000  4,000  4,000 
12,800  12,800 
1,600  1,600 
4,096  4,096  4,096 
240  240  120 
25,600  25,600  25,600 
32,000  32,000  32,000 
2,000  1,000 
In view of the titers shown by most antigens, a  1:16 dilution was in general considered 
a highly concentrated solution. Experiments were next carried out to determine the stability 
of antigens when held at  I°C.  in dilutions higher than 1:16.  The tests were done only at 
pit 7.0, as the results so far gathered showed that at this pH the antigens studied were mark- 
edly active. Each antigen was diluted 1:16, 1:64, and 1:256 in standard diluent and titrated 
at the end of the intervals stated in Table III. 
The results in Table HI show that at the end of 1 hour even when held as a  1:256 dilu- 
tion, the activity of the preparations remained similar to that shown at zero time; in fact, 
the titer was unchanged or diminished by only one dilution. With increasing time the titers 
of the antigens diminished; but even at the end of 4 hours there was an appreciable titer in 
most instances. For some of the antigens, dilution 1:256 was close to  the end-point, con- 
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Finally,  the  fitrations reported  in  Table  IV were  preliminary  fitrations done  in  con- 
junction with serum inhibition tests. 
The results shown in Table IV are reported as evidence that even in dilutions containing 
only 8 to 16 units, most antigens retained their titer unchanged for 10 minutes. This infor- 
mation was important in performing serUm inhibition tests, as  10 minutes was more than 
adequate for adding antigen to a  block of 150 tubes. 
It appears from the reported experiments that preparations could be secured 
from the indicated viruses which, when diluted and held at 1°C., were stable 
over a somewhat wide pH range, extending generally over 1 unit. They were 
particularly stable at pH 7.0 for viruses of Group B, and at pH 6.4 for those 
of Group A. This stability was found to hold even with  dilutions of antigen 
close  to the end-point. 
Antigens were not particularly stable at 22 ° or 37°C. when in the fluid state. 
No extensive investigation was carried out, however, at these temperatures. 
Division of Hemagglutinating Antigens into Two Distinct Groups.--By testing 
antigens at 4 ° or 22°C.,  it was possible  to demonstrate the presence of HA 
with a  number of arthropod-borne viruses;  those of the equine encephalitis 
group, however, failed to show any reaction. On further investigation, it was 
decided to test the effect of higher temperature of incubation in addition to 
that of pH. 
Antigens of practically all the viruses listed in Table I  were titrated simul- 
taneously at different pH values, from 5.6 to 7.6, and at 4 °, 22 °, and 37°C. Some 
of the results are shown in Table V, in which, for the sake of brevity, results 
at 22°C.  are not given as they were essentially similar to those at 4°C. The 
only differences were that at the latter temperature the titers were as a  rule 
one or more dilutions higher. With yellow fever antigens, on the other hand, 
the pattern was more stable and the pH range slightly wider at 22°C. 
In Table V it can be seen that antigens derived from EEE, WEE, and WEE 
reacted only when incubated at 37°C., with the exception that when there was 
a  reaction at 4°C., the titer was exceedingly low compared with that of the 
same preparation at 37°C. On the other hand, viruses such as dengue, Japanese 
B, and yellow fever reacted best at 4°C. At 37°C. reaction was either not de- 
tected, as with dengue Types 1 and 2, Ntaya, Uganda S, and yellow fever, or 
if present, its titer was lower--at pH 7.0,  considerably lower--than at 4°C., 
as was the case with Japanese B, St. Louis, and West Nile viruses.  Sindbis 
virus is the only agent thus far encountered which gave a  similar titer at 4 ° 
and 37°C.  Also the influence of ptI on the HA reaction and the connection 
between  it  and  temperature  of  incubation  was  noted.  Thus,  the  antigens 
agglutinating at 37°C.  did so at pH  5.6-6.4,  but not at pH  7.0  or higher. 
Viruses requiring temperatures of 4 ° or  22°C.  reacted better at a  higher pH. 
Reactions began to appear at pH 6.0 and extended in all cases tested beyond 
pH 7.0, usually 7.2-7.4; with some viruses the range of reaction extended to e.- 
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pH 7.6. From its pH requirements it can be seen that Sindbis virus was similar 
to the equine encephalitis viruses. 
It was noticed that if titrations  of antigens from viruses such as dengue or 
Ntaya--which were  negative  at 37°C.--were  shaken  and  then kept  at 4°C., 
no  reaction  occurred;  it  was  assumed  that  incubation  at  37°C.  resulted  in 
destruction  of the antigen  in 2  hours.  On the contrary,  in negative HA with 
the equine encephalitis  group of antigens that had been held at 4°C., shaking 
and  then  holding  at  37°C.  yielded  a  positive  reaction  with  a  titer  equal  or 
almost  equal  to  that  given  by  the  antigen  on  direct  incubation  at  37°C.  It 
was assumed  that  either  a  combination of antigen  and  erythrocytes had  oc- 
curred  at  4°C.  and  higher  temperature  was needed  for detection  of HA,  or 
else that the antigen had retained  its titer practically unchanged at 4°C.  and 
combined later at 37°C. 
It is to be recalled here also that with the antigens  of the equine encephalitis group a 
further manifestation  of reaction was observed between the hemagglutinin and the red cell 
suspension; in that group the reaction was a combination of agglutination  and hemolysis, as 
already described. With the antigens from the dengue-Japanese  B-yellow fever group, no 
such activity was seen at 4°C.; when, however, a reaction was positive at 37°C., as with 
Japanese  B virus, hemolysis similar in pattern, although  less complete than that shown by 
the viruses in Group A, was observed. 
To sum up,  the viruses that have thus far given positive HA could be as- 
sembled,  on  the  basis  of temperature  and  pH  requirements,  in  two  groups: 
Group A  comprising EEE, VEE, WEE, and Sindbis (see later); and Group B 
consisting  of dengue  Types  1  and  2,  Ilh6us,  Japanese  B,  Ntaya,  St.  Louis, 
Uganda  S,  West Nile  (Egypt  101  strain),  and yellow fever  (Asibi,  JSS,  and 
French neurotropic strains). 
Treatment of Sera in Order to Eliminate No~-Spedf~ InMbigors.--Sera deriving from repre- 
sentatives of different animal species, when tested in HA inhibition tests with the arthropod- 
borne  viruses, have been found  to possess non-specific inhibitors  in high titer; hence the 
necessity for devising methods toremove such inhibitors. Chanock and Sahin (10) advocated 
treatment  of sera  with  organic  solvents,  particularly  acetone  which was found effective 
against  inkibitors  for several viruses. Their  method  could be easily  reproduced;  however, 
when the extension of our work required the use of large numbers of sera, the acetone method 
was not entirely  practical.  In attempts to improve on this method, and also to secure ad- 
ditional  information  concerning properties  of the inhibitor,  the following trials  for its re- 
moval were made: acetone  precipitation  (10), chloroform extraction  (5), precipitation  with 
1:3 saturated ammonium sulfate, filtration through graded collodion membranes, adsorption 
in  ion  exchange resins, dialysis against  phosphate  buffer 0.1 and 0.02 M  in physiological 
saline,  filtration  through glass  filters,  filtration  through  Seitz pads,  and adsorption  with 
powdered asbestos. Sera were treated  as just indicated,  either subsequent  to heating at 56  ° 
or 60°C. for half an hour or without heating. These tests  led finally to the adoption  of the 
present  procedure  of filtration  of the  unheated  sera through  Seitz pads as the method of 
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In Table VI is given the result of one experiment in which normal mouse 
serum was subjected to different procedures. 
It can be seen that the titer of the non-specific inhibitor in heated or un- 
heated serum was 1:5,120 or higher. Of the methods used, dialysis, filtration 
through  sintered  glass,  or  filtration  through  collodion membranes  with  an 
average pore diameter  of 303  m# failed  to  remove the  inhibitor;  filtration 
through a collodion membrane with an average pore diameter of 69 mp wholly 
removed the inhibitor from heated serum and only partially from unheated 
serum. Finally, both treatment with acetone and Seitz filtration removed the 
inhibitor completely, better from unheated than from heated serum. In this 
TABLE  VI 
Removal of Normal  Mouse  Serum Intribltor for SL Louis Encephalitls  Virus 
Treatment of Serum 
i 
Heated at 56°C.  ! 
Not heated 
~one 
Acetone 
Dialysis 
Filtration, Seitz 
Filtration, glass 
Filtration,  collodion 303 m~, 
Filtration, collodion  69 n~, 
None 
Acetone 
Dialysis 
Filtration, Seitz 
Filtration, glass 
Filtration, collodion 303 m~ 
Filtration, collodion  69 n~ 
Reciprocal of dilution of serum 
10  20  40  80  160  320  540  1,280 2,550 $,120 
O*  0  0  0  0  0  0  0  0  0 
+  +  ++  ++  ++  ++  ++  ++  ++ 
.s,.  O  0  0  0  0  0  0  0  0 
±  +  +  ++  ++  ++  ++  ++  ++  ++ 
0  0  0  0  0  0  0  0  0 
0  0  0  0  0  0  0  0  0  + 
++  ++  ++  ++  ++  ++  ++  ++  ++  ++ 
o  o 
+  + 
o  o 
+  ++ 
-~-  0 
0  0 
0  0 
0  0  0  0  0  0  0  0 
+  ++  ++  ++  ++  ++  ++  ++ 
0  0  0  0  0  0  0  0 
++  ++  ++  ++  ++  ++  ++  ++ 
0  0  0  0  0  0  0 
0  0  0  0  0  O  0 
o  o  o  o  +  ++  ++  ++ 
'  See text for interpretation of signs in Tables VI to VIII; in all of these tables, 4 units of antigen were used. 
test, the antigen was used in dilution 1:1,024; actual titrations showed that 
the amount of antigen in the test was equivalent to 4 units. 
It was next necessary to determine whether or not those procedures which 
had  removed the  non-specific inhibitor from normal  mouse serum had  any 
action that might result in removing or in any way affecting the specific anti- 
body in mouse serum (Tables VII and VIII). 
In Table VII it can be seen that an unheated, hyperimmune mouse anti- 
serum against St. Louis virus had the same titer of inhibition of HA following 
Seitz treatment as it did after acetone treatment. Serum heated at 56°C. for 
30 minutes, and then treated either with acetone or by Seitz filtration, gave 
similar  titers  although  somewhat  lower than  those  obtained with  unheated 
serum.  Finally, filtration through a  69  mg  collodion membrane resulted  in 
almost complete elimination of the antibody when the serum had been previ- 
ously heated, but it was not so effective with the unheated serum. This type JORDI CASALS AND LENORA V.  BROWN  441 
of filtration could not, therefore, be used as a  means of preparing sera for inhi- 
bition tests. 
TABLE VII 
Hemagglutination Inhibition  of St.  Louis  Virus  Antigen  by  Hyperimraune Morse  Serum 
Treated to  Remove Non-Spedf~  Inhibitor 
Treatment of serum 
Heated at 
56°C. 
Not heated 
Acetone 
Filtration,  Seitz 
Filtration,  collo- 
dion 69 mv 
Acetone 
Filtration,  Seitz 
Filtration,  collo- 
dion 69 mu 
Reciprocal of dilution  of serum 
10  20  40  80  160  320  640  1,280  2,500  5,120 
0  0  0  0  0  0  0  +  ++  ++ 
0  0  0  0  0  0  ~  +  ++  ++ 
0  0  ~  ++  ++  ++  ++  ++  ++  ++ 
0  0  0  0  0  0  0  0  +  ++ 
0  0  0  0  0  0  0  0  +  ++ 
0  0  0  0  0  0  ~-  +  ++  ++ 
TABLE VHI 
Hemagglulination Inhibition of West Nile (Egypt 101) Virus Antigen by Monkey Convalescent 
Serum  Treated to Remove Non-Spedfi*  Inhibitor 
Time of 
bleeding 
Before in- 
fection 
34 days after 
infection 
Trestment of 
serum 
Acetone 
Filtration, 
Seitz 
Asbestos 
powder 
Acetone 
Filtration, 
Seitz 
Asbestos 
powder 
Reciprocal of dilution  of serum 
10  20  40  80  160  320  640  1.280  2,560 
+  +  ++  ++  ++  ++  ++  ++  ++ 
+  ++  ++  ++  ++  ++  ++  ++  ++ 
++  ++  ++  ++  ++  ++  ++  ++  ++ 
0  0  0  0  0  ±  +  ++  ++ 
0  0  0  0  0  0  +  ++  ++ 
-v  0  0  0  0  0  +  ++  ++ 
Non-specific inhibitors could also be removed by Seitz filtration from monkey 
sera  (Table VIII). In one of the experiments,  serum derived from a  monkey, 
before and after infection with West Nile (Egypt 101 strain) virus, was treated 
by  the  acetone  and  Seitz  filtration  methods  and  also  by  adsorption  with 
powdered  asbestos.  The  results  would  seem  to indicate  that  the  removal  of 
inhibitors  by  Seitz  filtration  was  more  a  phenomenon  due  to  adsorption  of 
elements in the serum by the material of the filter than one of simple filtration. 442  AGGLUTINA~ON  BY  ARTHROPOD-BORNEVIRUSES 
When sera were filtered through Seitz pads as a  1:5 dilution, similarly saris- 
factory results were obtained, except that occasionally the reaction in the tube 
containing that dilution of serum did not offer a  clear reading. 
TABLE  IX 
ttemagglutination InhiMtion with Mouse HypaeCmmune Sera 
Antigen 
Sentm  Group A  Group B 
Den. llh~us  J~l  p"  Nta-  St.  U~.  V~I~.  yf  EEE  Sind- VEE  WEE  guel  L.  bks  ya 
EEE 
Semliki Forest 
Sindbis 
VEE 
WEE 
Dengue Type 1 
Dengue Type 2 
Ilh6us 
Japanese B 
Ntaya 
Russian Far 
Eastern 
St. Louis 
Uganda S 
West  Nile 
(Egypt 101) 
Yellow fever 
(Asibi) 
Yellow fever 
OSS) 
2,560"  40  20  20 
40  40  40  20 
640  320 
640  10  5,120  20 
320  320  160  1,280 
0  0  0  0 
0  0  0  0 
0  0  0  0 
0  0  0  0 
0  0  0  0  0  0  0  0 
0  0  0  0  0  0  0 
0  0 
0  0  0  0  0  0  0 
0  0  0  0  0  0  0  0 
820  80  160  160  80 
40  20  10  20  40  80  40  20 
640  1,280  320  640  640  640  640  320 
320  640  640  640  320  320  320 
40  40  80  80  80  80  160 
80  20  80  80  80  40  40 
160  40  160  640  640  160  320 
160 
160  160  320  320  320  640  160 
0  0  0  20  10 1,280 
0  0  0 
0  0 
0  0 
0  0 
0  0  0 
0  0 
0 
0  40 
0  640 
0  160 
0  320 
0  40  80 
* Throughout Tables IX to XI, the figures signify the reciprocal of the highest dilution 
of serum giving complete inhibition of hemagghifination; a  zero indicates no inhibition at 
1:10 dilution. In all of these tables, 8 units of antigen were used. 
As a result of all these investigations a method was developed which removed 
non-specific inhibitors from sera deriving from all species tested--man, monkey, 
guinea pig, and mouse--for all viruses under consideration. The method de- 
scribed in the section on Materials and Methods resulted in no loss of specific 
antibody titers3 
Results  of Hemagglutination  Inhibition  Tests.--In  this  section  will  be  de- 
scribed results  of HA  inhibition tests done with  sera from mice,  guinea  pigs, 
and monkeys. The  studies with human  sera are to be reported at a  later date. 
1 Another simple and effective method of removing non-specific inhibitors from sera with- 
out affecting the antibody titer has been developed by Dr. D. H. Clarke. It is based on ad- 
sorption of sera with bentonite and will be described in detail at a later date. JORDI CASALS AND LENORA V. BROWN  443 
In all cases a  sufficient amount of serum was prepared  to allow for testing 
the same sample against all, or as many as possible, of the available antigens. 
The first dilution of serum was 1:10. On each separate test from 40 to as many 
as  100 sera were run against  8  units of antigen. 
Mouse sera: A  summary of some of the tests conducted with mouse hyper- 
immune sera is presented  in Table IX. 
Table IX shows that:  (a) antisera against a  number of viruses fall into two 
groups which  coincide with  the  antigen  Groups A  and  B  already  described; 
(b) within each group a  marked degree of cross-reaction was apparent; and (c) 
at no time was there any cross-reaction between a  serum from one group and 
an antigen from the other. 
The cross-reactions in Group B were of such magnitude  that the heterologous reaction 
often was of the same titer as the homologous one; for example, Japanese B antiserum gave 
approximately the same titer against all antigens in Group B, although it failed to react with 
any of the antigens in Group A. The only exception was yellow fever antiserum, Asibi strain, 
which had a high titer against a yellow fever antigen, yet reacted slightly or not at all with 
the remaining antigens in Group B. In Group A, the cross-reactions were not, as a rule, as 
pronounced as in Group B; thus VEE antiserum,  with a titer of 1:5,120  against  its  own 
antigen, gave titers of only 1 : 10 and 1 : 20 against two other members of the group and 1 : 640 
against  EEE. It is further noticeable  that the titers  of the sera were generally higher in 
Group A than in Group B. Hyperimmune antisera for viruses for which HA was not available 
were also included in these tests; as a result it could be seen that Semliki Forest  virus was 
related  to the viruses in Group A, while Russian  Far Eastern virus cross-reacted with  the 
agents in  Group B. 
Several  samples of normal mouse serum,  not shown in Table  IX, were in- 
cluded, as were sera from mice hyperimmunized with other viruses, following a 
method of immunization identical with the one used for the preparation of the 
active  sera;  these  viruses  were Anopheles  A,  California  BFS  283,  Coxsackie 
Types  1  and  2  (muscular  tissue  used  for  the  immunization),  herpes,  polio- 
myelitis Type 2, and Wyeomyia. At no time did any of these sera show the 
slightest  inhibitory  effect on any of the  hemagglutinins. 
Guinea pig sera:  The preparation of antisera from guinea pigs differed from 
that of antisera  from mice in that fewer injections of the  immunizing agents 
were given and  the  samples  tested  were from individual  animals rather  than 
from pools. 
Table X  gives a  summary of tests  which amply confirm the findings with 
mouse hyperimmune  sera  concerning the  existence  of two  distinct  groups of 
viruses,  with  the members of each group interrelated.  Table X  also reveals a 
louping ill serum reacting with antigens of Group B, though not with those of 
Group A.  Finally,  samples  of serum from 6  different  normal  guinea pigs,  as 
well as samples of serum from animals immunized with Anopheles B, Bunyam- 
wera,  Bwamba,  California,  GD  VII,  Mengo,  and  rabies,  failed  to  inhibit 
agglutination by any of the antigens. 
Monkey sera:  Monkeys were injected once with active virus and bled during 444  AGGLUTINATION BY ARTHROPOD-BORNE VIRUSES 
convalescence; from each animal there was available one sample of serum taken 
prior to injection and one or more at intervals following recovery. The results 
of the tests with sera from some of the monkeys are shown in Table XI. 
Tests with  antigens of Group A  are  not  tabulated  since  all  results  were 
negative. Antibodies inhibiting HA developed following infection with dengue 
Types  1  and  2,  St.  Louis,  West  Nile  (Egypt  101  strain),  and  yellow fever 
TABLE X 
H~agghdlnat~m  Inhibition with Guinea Pig  Immune Sera 
8 
9 
10 
11 
12 
13 
14 
15 
Serum 
Virus 
EEE 
Semliki Forest  . 
Group A 
Sindbis 
Sindbis 
Sindbis 
VEE 
WEE 
Ilh6us 
Japanese B 
Louping ill 
Russian Far 
Eastern 
Russian Far 
Eastern 
St. Louis 
EEE  Sind-  VEE WEE  bis 
160  160  10  40 
4O  4O 
0  40 
4O 
2O 
640  2O 
0  90 
0  0 
0  0 
0  0 
0  0 
0  0 
Antigen 
Group  B 
Den- Ilh- J  Nta- St.  U~.  WE  ~  guel  ~us  ~P"  ya  L.  "  Yf 
0  0 
0 
0  0  0  0 
0  0 
0  0 
0  0  0  0  0  0 
0  0 
160  820  320  320  160 
40  40  80  80  40 
40  20  40  40 
40  40  40  80  160  80 
10  40  10  10  10  20 
10  820 
160 
160 
80  8O 
0 
,c 
0  0 
0  0 
0 
0 
0  0  20  40  80  160  40 
20  20  40  40  West Nile (Egypt 
101) 
West Nile (Egypt 
101) 
0  0 
80 
20 
20  20  20  20  40 
80  20 
160  20 
viruses. There was a degree of cross-reaction which is, however, less pronounced 
here  than with  the  other  animal sera  tested.  In monkey 4,  antibodies were 
detectable  almost  1  year  after  infection.  Monkeys  infected  with  different 
strains of yellow fever developed antibodies promptly with high titers and a 
minimum of cross-reaction.  Finally,  in addition  to  the  8  samples of normal 
monkey serum shown, an additional  16 normal monkeys possessed sera  that 
failed to inhibit HA by any of the antigens tested. 
Recapitulation of the results with animal sera:  From the results observed with 
animal sera, hyperimmune as well as convalescent, it is concluded that an HA 
inhibition reaction could be demonstrated which was specific in the sense that JORDI CASALS AND LENORA V.  BROWN  445 
group antibodies were detected as well  as antibodies against  the agent with 
which the animal had been vaccinated or infected. With hyperlmmune mouse 
sera, particularly in Group B, the homologous and heterologous reactions were 
TABLE XI 
Hemagglu[inoglon Inhibigon with Monkey Convalestent Scra 
Sertun 
Mon- 
key  Virus 
O. 
1  Dengue Type 1 
Dengue Type 2 
St. Louis 
West Nile (Egypt 101) 
Yellow fever (Asibi) 
Yellow fever (JSS) 
Yellow fever (JSS) 
Yellow fever (Ogbomosho) 
after in. 
jecfion 
days 
0 
42 
156 
0 
109 
130 
334 
0 
41 
0 
34 
88 
118 
145 
307 
0 
19 
0 
41 
0 
41 
0 
13 
Antigen 
De~-6Ilhu~ J'~p. Nts-St.  U~.  W(.~I~.  yf 
gue 1  ya  L. 
0  0  0  0  0  0  0  0 
160  20  20  40  20  80  40 
1fl0  20  20  40  40  20  10 
0  0  0  0  0  0  0 
10  0  10  20  0  20  10 
10  10  10  10  10  10  10 
10  10  10  10  10  10 
0  0  0  0  0  0 
0  10  0  40  10  10 
0  0  0  0  0  0  0 
4040408080  320  40 
20  0  10  10  20  80  10 
20  10  10  20  20  80  10 
20  0  10  20  10  40  10 
10  0  10  20  10  40  10 
0  0  0  0  0  0 
4O  20  4O  40  80  640 
0  0  0  0  0  0 
20  20  10  20  20  840 
0  0  0  0  0  0 
20  20  20  40  20  160 
0  0  0  0  0  0 
80  10  40  80  80 1,280 
of almost the same titer.  The consistent lack of inhibition by the large num- 
ber of normal  sera,  and  by sera from animals immunized with viruses other 
than the ones in Groups A and B, was taken as evidence that the inhibitions 
of HA described  here were  not due  to a  non-specific inhibitor  such  as that 
shown to be present in normal, untreated  sera. 446  AGGLUTINATION  BY  ARTHROPOD-BORNE  VIRUSES 
DISCUSSION 
The work of Sabin and his associates showed the possibility of using HA 
and HA inhibition tests for the study of the arthropod-borne viruses. As re- 
ported here, that work has now been elaborated and extended to other viruses, 
particularly in the equine encephalitis group. Moreover, it has been possible 
to introduce a certain degree of systematization and uniformity in the methods 
for detection of HA, with the result that all  tests can now be done with a 
minimum of easily controlled variables. There is then available an additional 
tool for the investigation of this large and complex group of viruses, particu- 
larly the investigation of their antigenic relationships. 
Over the past 15 years information has been gathered showing that by neutrali- 
zation, complement-fixation,  and cross-resistance  tests,  certain immunological rela- 
tionships  can be established  among  certain viruses  in  this group.  Smithbum  (39) 
showed a relationship  to exist between Japanese B, St. Louis, and West Nile viruses; 
Casals  and Webster (40) showed that louping  ill and Russian  Far Eastern viruses 
were closely connected,  almost identical,  agents.  Sabin  (41) found  by complement 
fixation that the viruses of dengue Type 1, dengue Type 2, Japanese B, West Nile, 
and yellow fever had common antigenic constituents.  Havens d aL (42) reported the 
crossing of EEE with WEE virus by complement-fixation tests. As might be expected, 
improved  techniques  resulted  in  uncovering  serological  crossings  which  with  less 
sensitive methods either were missed or if reported led to controversy. Sabin empha- 
sized the usefulness of high-fitered antigens in his work on complement fixation; and 
in this laboratory and that of The Rockefeller Institute for Medical  Research, the 
development of  highly potent complement-fixing antigens  extracted with  acetone- 
ether has led to the discovery of additional crossings among arthropod-borne viruses 
which had not been hitherto detected (43). 
These observations  fit in well with the concepts  discussed by Olitsky  and Casals 
(44), Theiler (45), and Sabin (46) concerning the probable existence of a large group 
of arthropod-borne viruses having common antigenic  constituents, and the practical 
consequences that this fact might have in epidemiological studies. 
The work reported here brings forth clear-cut serological crossings among 
arthropod-borne viruses by the use of the HA test, and the separation of a 
number  of  them  into  two  completely distinct  groups.  Whether  or not  this 
classification corresponds to deeper differences in the nature or essential prop- 
erties of the viruses involved remains to be seen. It seems apparent at this time, 
however, that such a  sharp grouping might be used to advantage in the sys- 
tematization of the viral agents. 
In the HA tests no crossing was noted between the viruses in Group A and 
those in Group B. Whether this applies only to the results of HA tests, or to 
neutralization and complement-fixation tests as well, is still to be thoroughly 
investigated.  Smithburn  (47),  for  example,  found  that  louping  ill  immune 
serum neutralized EEE virus; also that Ntaya antiserum neutralized to some ]ORDI  CASALS AND  LENORA  V.  BROWN  447 
extent Anopheles A virus. Such results are at variance with the observations 
reported here, and they may be proof that the particular test used influences 
the type of relationships elicited.  That this may well be the case seems to be 
partly borne out by parallel  studies using neutralization and  complement- 
fixation tests now being conducted in this laboratory on the same specimens 
of sera.  It would appear  that HA inhibition shows  the greatest serological 
overlap, complement fixation less, and neutralization least. A recent reinvesti- 
gation, however, of neutralization tests with certain of the arthropod-borne 
viruses resulted in serological relationships of a degree hitherto unrecognized. 
Thus, several dengue Type I  monkey convalescent sera neutralized 100 LDs0 
of St. Louis virus (48). 
The advantage of the serological overlap by HA tests is that it facilitates 
the grouping of the arthropod-borne viruses and their immune sera, since even 
sera of only moderate homologous titer are apt to exhibit cross-reactions;  the 
disadvantage is that no definite etiology can be established in epidemiological 
surveys. In the latter case when sera were tested against numerous antigens 
of a related group, the difference in the antibody titer for the presumed etiologi- 
cal agent and for the related viruses was apt to be only one or two dilutions, 
which is too small to be definite. Furthermore, there is the possibility  that the 
detected antibodies might have been originated by the action of an incitant, 
still  undiscovered, but  belonging  to  one of the two groups here described. 
Where the HA inhibition test may be of use in epidemiological  work is  in 
preliminary screening;  that is, by testing sera against one or two antigens of 
Groups A and B. 
CONCLUSIONS 
Through the use of acetone and ether extraction of brain tissue from new- 
born mice infected with certain arthropod-borne viruses,  it has been possible 
to demonstrate hemagglutinins for chick erythrocytes associated with the fol- 
lowing viruses: dengue Type 1, dengue Type 2, Eastern equine encephalitis, 
Ilh6us,  Japanese B, BTtaya, St. Louis,  Sindbis,  Uganda S, Venezuelan  equine 
encephalitis,  West Nile (Egypt 101 strain), Western equine encephalitis,  and 
yellow fever (viscerotropic  and neurotropic strains). 
On the basis of the temperature and pH required for reaction, the viruses 
can be assembled in  two groups: A--those that require 37°C. and a  pH of 
about 6.4, comprising  Eastern, Venezuelan,  and Western equine encephalitis 
and Sindbis viruses; and B--those that require either 4  ° or 22°C. and a pH 
of about 7.0, comprising  dengue Types 1 and 2, Ilh6us,  Japanese B, Ntaya, 
St. Louis, Uganda S, West Nile, and yellow fever viruses. 
A method of eliminating non-specific inhibitory substances present in sera 
was developed. The method consists essentially of filtration through Seitz pads. 
Extensive serological  crossings  were found among viruses of each group, 448  AGGLUTINATION  BY  ARTHROPOD-BORNE  VIRUSES 
while  antisera  of one  group  failed  consistently  to  cross-react  with  antigens 
of the other. 
Antisera  deriving  from animals  immunized  with  certain  viruses for which 
no hemagglutinins  could be developed by the present  method,  reacted  with 
members of either  one or the other  group. Thus  Semliki Forest virus would 
appear to belong to Group A, and Russian Far Eastern and louping ill viruses 
to Group B. 
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